Search results
Contact details: Department of Integrative Biomedical Sciences. Wernher & Beit North level 3. Institute of Infectious Disease and Molecular Medicine. Faculty of Health Sciences, University of Cape Town. Anzio Road. Observatory, 7925. South Africa. Tel: +27 21 406 6938 (office) Email: stefan.barth@uct.ac.za.
Stefan Barth View Targeted human cytolytic fusion proteins at the cutting edge: Harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells
1,973 Followers, 549 Following, 289 Posts - Stefan Barth (@barthsman) on Instagram: "Fulltime Coach and Author | Endurance combined with Medical Fitness and Acupressure | Passion for Ultracycling & Bikepacking | Coaching & Books ⬇️⬇️⬇️".
- 1973
BARTH, Prof Dr Dr Stefan - Position presently held. South African Research Chair in Cancer Biotechnology, Tier 1 (NRF 47904) Research interests. Knowledge-driven development of disease-specific diagnostic and therapeutic fusion proteins. Main areas of research/expertise.
University of Cape Town: Cape Town, Western Cape, ZA. 2015-05-01 to present | Head, Medical Biotechnology & Immunotherapy Unit (Institute of Infectious Disease and Molecular Medicine) Employment. Show more detail. Source : Prof. Dr. Dr. Stefan Barth.
Sep 1, 2023 · open access. Abstract. Immunotherapy has revolutionized the landscape of cancer treatment. However, single immunotherapy only works well in a small subset of patients. Combined immunotherapy with antitumor synergism holds considerable potential to boost the therapeutic outcome.
Stefan Barth. Offers cutting-edge information on the development of antibody drug conjugates and recombinant immunotoxins. Explores related basic biological and chemical technologies and promotes new developments toward clinical applications. Primarily aimed at postgraduate students, researchers and clinicians.
